[
  {
    "ts": "2026-01-29T14:00:00+00:00",
    "headline": "Automata Raises $45M Series C to Build the Operating System for AI-Ready Labs",
    "summary": "LONDON, January 29, 2026--Automata, the lab automation company building fully integrated, AI-ready platforms for life sciences, today announced the close of a $45 million Series C funding round led by Dimension with participation from Danaher Ventures, Tru Arrow Partners, Octopus Ventures, Entrepreneurs First, and others. The round also includes a strategic investment partnership with Danaher Corporation, with Murali Venkatesan Ph.D., Global Head of Danaher Ventures and Vice President of Science",
    "url": "https://finance.yahoo.com/news/automata-raises-45m-series-c-140000947.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "55deab55-7c45-331e-bafc-3bb8f73e5ef9",
      "content": {
        "id": "55deab55-7c45-331e-bafc-3bb8f73e5ef9",
        "contentType": "STORY",
        "title": "Automata Raises $45M Series C to Build the Operating System for AI-Ready Labs",
        "description": "",
        "summary": "LONDON, January 29, 2026--Automata, the lab automation company building fully integrated, AI-ready platforms for life sciences, today announced the close of a $45 million Series C funding round led by Dimension with participation from Danaher Ventures, Tru Arrow Partners, Octopus Ventures, Entrepreneurs First, and others. The round also includes a strategic investment partnership with Danaher Corporation, with Murali Venkatesan Ph.D., Global Head of Danaher Ventures and Vice President of Science",
        "pubDate": "2026-01-29T14:00:00Z",
        "displayTime": "2026-01-29T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/4aa00bc8967c6ebe2c7df339c2c225f9",
          "originalWidth": 480,
          "originalHeight": 416,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G.Zt6HGX0cX8rgzs1YlDNA--~B/aD00MTY7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/4aa00bc8967c6ebe2c7df339c2c225f9.cf.webp",
              "width": 480,
              "height": 416,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NYOCjah605BFAVwAPRencQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/4aa00bc8967c6ebe2c7df339c2c225f9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/automata-raises-45m-series-c-140000947.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/automata-raises-45m-series-c-140000947.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T05:31:36+00:00",
    "headline": "DHR Q4 Deep Dive: Bioprocessing and Diagnostics Drive Steady Performance Amid Muted End Markets",
    "summary": "Diversified science and technology company Danaher (NYSE:DHR) met Wall Streets revenue expectations in Q4 CY2025, with sales up 4.6% year on year to $6.84 billion. Its non-GAAP profit of $2.23 per share was 1.8% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/dhr-q4-deep-dive-bioprocessing-053136981.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "c062af2a-60f1-3f7c-94e7-7107b8a154dd",
      "content": {
        "id": "c062af2a-60f1-3f7c-94e7-7107b8a154dd",
        "contentType": "STORY",
        "title": "DHR Q4 Deep Dive: Bioprocessing and Diagnostics Drive Steady Performance Amid Muted End Markets",
        "description": "",
        "summary": "Diversified science and technology company Danaher (NYSE:DHR) met Wall Streets revenue expectations in Q4 CY2025, with sales up 4.6% year on year to $6.84 billion. Its non-GAAP profit of $2.23 per share was 1.8% above analysts’ consensus estimates.",
        "pubDate": "2026-01-29T05:31:36Z",
        "displayTime": "2026-01-29T05:31:36Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/f7c48f94496cc685707bb82fa48852a9",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "DHR Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lQBC7nIOUIxAsi7pN3Mziw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/f7c48f94496cc685707bb82fa48852a9.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NL6F_XQC1SIlNraLaRAr1g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/f7c48f94496cc685707bb82fa48852a9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/dhr-q4-deep-dive-bioprocessing-053136981.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/dhr-q4-deep-dive-bioprocessing-053136981.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]